Editors:
- Comprehensively reviews every aspect of prostate cancer screening, including the latest discoveries in biomarker research
- Outlines current screening policies by continent and presents the relative ongoing prospective screening trials around the globe
- Includes supplementary material: sn.pub/extras
Part of the book series: Current Clinical Urology (CCU)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (27 chapters)
-
Front Matter
-
Prostate-Specific Antigen
-
Front Matter
-
-
Risk Assessment for Prostate Cancer
-
Front Matter
-
-
Recent Biomarkers for Prostate Cancer
-
Front Matter
-
About this book
More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world’s leading experts on prostate cancer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world’s experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.
Reviews
From the reviews of the second edition:
"This compilation of 27 chapters written by well known urology experts covers a wide range of topics from trends in PSA screening to PSA isoforms … .This book is most suitable for statisticians, scientists, or clinicians who wish to draw their own conclusions regarding PSA screening and related topics. … This book is a superb resource for anyone interested in PSA screening … . It is also an excellent reference for anyone interested in comparing the various studies and controversies from different healthcare systems … ." (Jack H. Mydlo, Doody’s Review Service, May, 2009)
Editors and Affiliations
-
Department of Mathematics, Technical University, Garching, Germany
Donna P. Ankerst
-
Associate Professor, Departments of Urology, and Epidemiology/Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, USA
Donna P. Ankerst
-
Member, Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, UK
Catherine M. Tangen
-
Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, USA
Ian M. Thompson
Bibliographic Information
Book Title: Prostate Cancer Screening
Book Subtitle: Second Edition
Editors: Donna P. Ankerst, Catherine M. Tangen, Ian M. Thompson
Series Title: Current Clinical Urology
DOI: https://doi.org/10.1007/978-1-60327-281-0
Publisher: Humana Totowa, NJ
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Humana Press 2009
Hardcover ISBN: 978-1-60327-280-3Published: 11 February 2009
Softcover ISBN: 978-1-62703-853-9Published: 22 November 2014
eBook ISBN: 978-1-60327-281-0Published: 24 January 2009
Series ISSN: 2197-7194
Series E-ISSN: 2197-7208
Edition Number: 2
Number of Pages: XVI, 397
Topics: Oncology, Urology, Epidemiology, Medicine/Public Health, general, Health Informatics